Celsius Holdings heads into its Q1 earnings print on May 28 with a cluster of insider buying at current lows — a signal that cuts against the bearish positioning that has dominated the story for weeks.
The insider angle is the most notable development this week. CEO John Fieldly and President/COO Eric Hanson both bought shares in the $29–$30 range on May 21 and 22, with Fieldly adding 8,475 shares at $29.36 and Hanson purchasing 7,500 at $29.04. Lead Independent Director Hal Kravitz also stepped in at $29.73. Three C-suite names buying within two days, near a multi-year low, is a meaningful cluster — the net 90-day insider position is a modest positive at roughly 59,000 shares net bought. Earlier sells by Fieldly and the CFO in February, when the stock traded above $53, were smaller in dollar terms than the recent buys at these levels, which reinforces the directional read.
Short positioning remains elevated but has not pressed higher into the print. Short interest is 9.5% of free float — essentially unchanged from where it was reported in Tuesday's earnings preview note. The one-month build of roughly 9% is already in the price. Notably, shorts edged back slightly on the week, down about 0.6%. The ORTEX short score is 62.4, near the lower decile of the universe, but the borrow market itself shows no distress: cost to borrow is just 0.39%, and availability has loosened to 190% — meaning nearly two shares remain lendable for every share already borrowed. That is comfortable territory, well above the 52-week tightest reading of 160%. There is no squeeze pressure in the lending pool.
Options traders remain strikingly calm for a stock sitting on a 37% year-to-date decline with earnings tomorrow. The put/call ratio is 0.41, fractionally below its 20-day average of 0.42 and near the low end of its 52-week range of 0.38–0.70. A z-score of -0.31 confirms this is not a market buying downside protection aggressively into the release. That absence of hedging activity is the contrast worth flagging: shorts are present but not crowding in, and options traders are not positioning for a disaster print.
The Street is still constructive in direction, but has been methodically cutting numbers. BNP Paribas lowered its target to $57 from $70 on May 26 while keeping an Outperform. Morgan Stanley trimmed to $55 from $64 after the last print. JP Morgan, meanwhile, nudged its Overweight target up to $70 from $67 following Q1 results — the one voice moving in the other direction. The consensus mean target is $61, roughly double the current price of $29.67. That gap is wide enough to warrant a consistency check: the stock has fallen so sharply year-to-date that analyst targets are lagging the price move, and several of these figures will likely be revised post-print. The bull case centres on PepsiCo distribution, the Alani Nu integration, and forward EPS growth that ranks in the 92nd percentile of the universe on a 12-month forward basis. The bear case points to slowing top-line momentum and intensifying competition in zero-sugar energy.
The recent earnings history offers a sobering reference point. The last major print on May 8 produced a 10.6% single-day decline and an 11.9% five-day loss. The prior comparable event showed a 1.5% day-one move but then gave up 11.6% over the following week. Peers MNST and PRMB both managed modest weekly gains of -1.3% and +2.0% respectively, underlining how stock-specific this story has become. The question going into tomorrow's print is whether the insider buying in the $29–$30 zone reflects confidence in the Q1 numbers, or simply management's view that the valuation — a PE of 16.6x and EV/EBITDA near 11.6x — has compressed enough to warrant buying regardless of the near-term headline.
See the live data behind this article on ORTEX.
Open CELH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
Celsius Holdings heads into its May 28 earnings print with short sellers aggressively rebuilding positions while the options market tells the opposite story — a rare and charged divergence for a stock already down 15%…
Celsius Holdings enters its Q1 2026 earnings print tomorrow with short sellers quietly adding exposure, analysts trimming targets but holding buy ratings, and options traders leaning more bullish than usual — a setup…
